Personalized diet may boost Well-Being in advanced cancer patients
NCT ID NCT07406789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized diet can improve quality of life in 100 women with advanced gynecologic or breast cancer who are receiving antibody-drug conjugate therapy. Participants will either follow a diet tailored to their needs or receive general Mediterranean diet advice. The goal is to see if personalized nutrition helps them feel better during treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- personalized dietary intervention
- What this could lead to
- If it works, this could show that tailoring diet to individual needs helps women with advanced cancer feel better during treatment.
- What could go wrong
- This is a small, early-phase study focused on quality of life, not survival. The diet may not provide noticeable benefits, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Hospital Universitario 12 Octubre
Madrid, Madrid, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- A simple drain may slash wound infections after gynecologic cancer surgery
- Blood tests could reveal hidden resistance in breast cancer
- Triple threat: three new targeted drugs join forces with immunotherapy to attack Hard-to-Treat breast cancer
- New drug sequence aims to outsmart advanced breast cancer